Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 2/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | CTSL | P07711 | 1/20 | 0.31 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17367989 | 0.90 | CTSK (0.37) | CTSKCTSLCTSSNAAAPTGS2 | |
| SCHEMBL17367991 | 0.84 | CTSK (0.37) | CTSKCTSLCTSSNAAA | |
| SCHEMBL17367980 | 0.84 | CTSL (0.30) | CTSKCTSLCTSS | |
| SCHEMBL17367993 | 0.83 | CTSK (0.35) | CTSKCTSLCTSSNAAAPTGS2 | |
| SCHEMBL17365868 | 0.82 | KIF11 (0.33) | — | |
| SCHEMBL17367999 | 0.80 | FFAR4 (0.35) | CTSKCTSLCTSSNAAA | |
| SCHEMBL17368000 | 0.80 | CTSL (0.34) | CTSKCTSLCTSS | |
| SCHEMBL17368009 | 0.80 | CTSK (0.35) | CTSKCTSLCTSSNAAA | |
| SCHEMBL17367990 | 0.79 | CTSL (0.34) | CTSKCTSLCTSS | |
| SCHEMBL17367995 | 0.78 | CTSK (0.32) | CTSKNAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10023799-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2018-07-17 | — | — | US | disclosed |
| US-20150376504-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10023799-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | PIEZO1, ROCK1, RCC1 | CTSK 1913/4885GRM2 3312/4885CTSL 2885/4885 |
| US-20150376504-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | PIEZO1, ROCK1, RCC1 | CTSK 1913/4885GRM2 3312/4885CTSL 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.